Testing for NRG1 fusions- The new kid on the block of actionable pathogenic gene fusions

Pranil K. Chandra, DO, explores pathogenic gene fusions as oncogenic drivers and actionable biomarkers in precision oncology, focusing on NRG1 fusions.